United States Proteomics Market Insight
Published: 09 June 2026 | Report Format: Electronic (PDF)
The United States Proteomics Market is projected to grow at a CAGR of 12.4% from 2025 to 2035, driven by increasing investments in precision medicine, expanding protein analysis applications in drug discovery, rising chronic disease prevalence, and growing adoption of advanced proteomics technologies
United States Proteomics Market Insights Forecasts to 2035
- The United States Proteomics Market Size Was Estimated at USD 15.8 Billion in 2025
- The Market Size is Expected to Grow at a CAGR of around 12.4% from 2025 to 2035
- The United States Proteomics Market Size is Expected to Reach Approximately USD 50.8 Billion by 2035
Notable Insights for the United States Proteomics Market
- Segmentation on the basis of Product Type indicates that Reagents, Kits & Consumables hold the dominant position in the United States Proteomics Market in 2025 with a market share of nearly 48% due to their extensive use in protein identification, quantification, and biomarker discovery studies.
- Segmentation on the basis of Technology indicates that Mass Spectrometry-based Proteomics holds the dominant position in the market in 2025 with a market share of around 42% owing to its high sensitivity, accuracy, and widespread adoption in pharmaceutical and clinical research.
- Worldwide projected revenue of Thermo Fisher Scientific Inc. in fiscal year 2025 is expected to exceed USD 45 billion, supported by strong demand for life sciences instruments, analytical technologies, and proteomics solutions.
- Increasing investments in precision medicine, biomarker discovery, and personalized therapeutics are expected to drive market growth, while advanced proteomics platforms help improve protein identification accuracy by up to 35% and accelerate drug development workflows by nearly 30%.
Download the eBook (ToC)
Why Buy This Report
- Provides an in-depth analysis of the impact of precision medicine, biomarker discovery, and technological advancements on the growth of the United States Proteomics Market.
- Offers strategic insights regarding innovations such as artificial intelligence-enabled proteomics analysis, next-generation mass spectrometry, single-cell proteomics, and cloud-based bioinformatics platforms.
- Assists stakeholders in evaluating competitive benchmarking, R&D investments, strategic collaborations, and expansion initiatives undertaken by major proteomics solution providers.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the United States Proteomics Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in United States Proteomics Market
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Bruker Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Waters Corporation
- PerkinElmer Inc.
- Revvity, Inc.
- Illumina, Inc.
- Standard BioTools Inc.
Recent Developments:
- In September 2025, Thermo Fisher Scientific introduced an advanced high-resolution mass spectrometry platform designed to improve protein characterization and accelerate biomarker discovery applications.
- In June 2025, Bruker Corporation expanded its proteomics portfolio with AI-assisted data analysis solutions aimed at improving throughput and reproducibility in large-scale protein research studies.
Market Segmentation:
United States Proteomics Market, By Product Type
- Instruments
- Reagents & Consumables
- Software & Bioinformatics Tools
- Services
- Protein Microarrays
United States Proteomics Market, By Technology
- Mass Spectrometry
- Chromatography
- Protein Microarrays
- X-ray Crystallography
- Nuclear Magnetic Resonance (NMR) Spectroscopy
- Bioinformatics & Data Analytics
United States Proteomics Market, By Application
- Drug Discovery & Development
- Clinical Diagnostics
- Biomarker Identification
- Personalized Medicine
- Academic & Research Applications
- Agricultural & Food Research
United States Proteomics Market, By End User
- Pharmaceutical & Biotechnology Companies
- Academic Research Institutes
- Clinical Laboratories
- Contract Research Organizations (CROs)
- Government & Public Research Organizations
Expert Views:
The United States Proteomics Market is expected to witness robust growth due to increasing demand for precision medicine, rising research funding, and continuous advancements in protein analysis technologies. The integration of artificial intelligence, machine learning, cloud-based bioinformatics, and next-generation proteomics platforms is anticipated to enhance analytical capabilities, improve research efficiency, and create substantial growth opportunities across healthcare, pharmaceutical, and biotechnology sectors.
Author: Sanket and Pranali By Decisions Advisors and Consulting